# QuANTUM-WILD (NCT06578247)

> Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06578247
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Daiichi Sankyo
- Conditions: Leukemia
- Interventions: Quizartinib; Placebo; Chemotherapy
- Enrollment: 700
- Primary outcome: Overall Survival (Arm A vs Arm B)

## Commentary we found

- YouTube: 13
- Podcasts: 5

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=quantum-wild-nct06578247

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT06578247", "email": "<work email>"}; the inbox owner confirms by the emailed link.